Riskpilot← Back to searchSign inGet full accessPharmapress Oy
OYActiveY-tunnus 1089493-3Elimäenkatu 5Publishing of journals and periodicals · NACE 5813Est. 19975 employees
Revenue 2025
EUR 1,3M
-10% vs 2024
EBITDA margin
8.6%
-41% vs 2024
Equity ratio
86.0%
Financial strength
Net profit 2025
EUR 65K
-53% vs 2024
| Revenue | EUR 1,3M | -10% |
| EBITDA | EUR 108K | -41% |
| Net profit | EUR 65K | -53% |
| Total assets | EUR 545K | -17% |
| Equity | EUR 469K | -14% |
| Employees | 5 | — |
Legal name
Pharmapress Oy
Y-tunnus number
1089493-3
Legal form
Osakeyhtiö
NACE code
5813 · Publishing of journals and periodicals
Founded
1. huhtikuuta 1997
Share capital
EUR 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on apteekkitoimintaan liittyvien painettujen ja digitaalisten aikakauslehtien, kirjojen ja muiden julkaisujen kustantaminen ja tuottaminen sekä apteekki- ja lääkealan tapahtuma- ja koulutustoiminta.
Address
Elimäenkatu 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 175 | 1 374 | 1 341 | 1 399 | 1 254 |
| Staff expenses | −317 | −258 | −276 | −249 | −251 |
| EBITDA | 176 | 167 | 133 | 183 | 108 |
| Depreciation & amort. | −0 | −3 | −6 | −19 | −27 |
| EBIT | 176 | 164 | 128 | 164 | 81 |
| Net financials | −0 | 0 | 0 | 10 | 0 |
| Profit before tax | 176 | 164 | 128 | 174 | 81 |
| Tax | 28 | 33 | 26 | 35 | 16 |
| Net profit | 148 | 132 | 102 | 139 | 65 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 653 | 651 | 699 | 659 | 545 |
| Equity | 541 | 533 | 504 | 543 | 469 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 111 | 119 | 195 | 116 | 76 |
| Total debt | 111 | 119 | 195 | 116 | 76 |
EBITDA margin
8.6%
This company
15.8%
Market median
-46% vs market
20212025
Equity ratio
86.0%
This company
38.2%
Market median
+125% vs market
20212025
Return on equity
13.8%
This company
18.4%
Market median
+25% vs market
20212025
Net profit margin
5.2%
This company
8.1%
Market median
-36% vs market
20212025
Asset turnover
2.30×
This company
1.12×
Market median
+105% vs market
20212025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EJ Chief Executive Officer | Chief Executive Officer | 2019 |
| Former (2) | ||
JP Audit | Audit | 2012 – 2023 |
SE Chief Executive Officer | Chief Executive Officer | 2019 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2023 | |
| Board of Directors | 2016 | |
| Chairperson | 2019 | |
| Board of Directors | 2023 | |
| Former (6) | ||
| Board of Directors | 2020 – 2025 | |
| Chairperson | 2016 – 2019 | |
| Board of Directors | 2016 – 2020 | |
| Board of Directors | 2019 – 2023 | |
| Board of Directors | 2019 – 2023 | |
| Board of Directors | 2016 – 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmapress Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jaana Pepita Salmi | Audit | 0 companies |
| Sisko Elina Aaltonen | Chief Executive Officer | 0 companies |
| Erkki Juhani Kostiainen | Chief Executive Officer | 0 companies |
| Pete Samuli Saarnivaara | Board of Directors | 0 companies |
| Elina Maria Yrjölä-Suhonen | Board of Directors | 0 companies |
| Eija Hannele Kari | Chairperson | 0 companies |
| Timo Risto Antero Auvinen | Board of Directors | 0 companies |
| Kari Pekka Juhani Väisänen | Board of Directors | 0 companies |
| Merja Elina Hirvonen | Board of Directors | 0 companies |
| Sari Marjaana Westermarck | Chairperson | 0 companies |
| Kirsi Katariina Myllynpää | Board of Directors | 0 companies |
| Antti Mikael Vaara | Board of Directors | 0 companies |
| Anna Maarika Nurmi | Board of Directors | 0 companies |
| Eila Inkeri Tervola | Board of Directors | 0 companies |